FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:683-684 March 9, 1995 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Haahtela, T. PubMed Citation

To the Editor: Although the recent article¹ and editorial² (Sept. 15 issue) on treating mild asthma with inhaled corticosteroids are valuable, they perpetuate a myth. Neither questions the need for large doses. Haahtela et al.¹ imply that an initial dose of 1200 µg is needed to achieve control of asthma, and Drazen and Israel² discuss treatment with high-dose inhaled corticosteroids as if this was the only accepted therapeutic option. They conclude that "there are sufficient unanswered questions about long-term therapy with high-dose inhaled corticosteroids that such treatment should be reserved for patients with moderate asthma." They go on to state . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Blais, L., Suissa, S., Boivin, J.-F., Ernst, P. (1998). First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax 53: 1025-1029 [Abstract] [Full Text]